Sarepta Therapeutics
SRPT
#1466
Rank
ยฃ9.24 B
Marketcap
ยฃ96.93
Share price
0.09%
Change (1 day)
-0.65%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Net assets

Net assets on the balance sheet as of June 2024 : ยฃ0.82 B

According to Sarepta Therapeutics 's latest financial reports the company has ยฃ0.82 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Sarepta Therapeutics - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$ยฃ0.67 B111.98%
2022-12-31$ยฃ0.31 B-53.6%
2021-12-31$ยฃ0.68 B22.89%
2020-12-31$ยฃ0.55 B-9.5%
2019-12-31$ยฃ0.61 B-23.79%
2018-12-31$ยฃ0.80 B38.54%
2017-12-31$ยฃ0.58 B114.01%
2016-12-31$ยฃ0.27 B112.66%
2015-12-31$ยฃ0.12 B-19.34%
2014-12-31$ยฃ0.15 B6.29%
2013-12-31$ยฃ0.14 B95.7%
2012-12-31$ยฃ76.48 M283.27%
2011-12-31$ยฃ19.95 M-1189.88%
2010-12-31$-ยฃ1.84 M-112.44%
2009-12-31$ยฃ14.72 M34.92%
2008-12-31$ยฃ10.91 M-17.42%
2007-12-31$ยฃ13.21 M-31.37%
2006-12-31$ยฃ19.25 M-38.13%
2005-12-31$ยฃ31.11 M127.21%
2004-12-31$ยฃ13.69 M-44.03%
2003-12-31$ยฃ24.46 M67.08%
2002-12-31$ยฃ14.64 M-30.46%
2001-12-31$ยฃ21.05 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
ยฃ13.86 B 1,589.49%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.33 B-140.08%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.93 B 13.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.37 B-144.16%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ2.34 M-100.28%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.75 B-191.00%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ29.57 M-96.40%๐Ÿ‡บ๐Ÿ‡ธ USA